Schwarz TF, Johnson C, Grigat C, Apter D, et al. Three dose levels of a maternal respiratory syncytial virus vaccine candidate are well tolerated and immunogenic in a randomized trial in non-pregnant women. J Infect Dis 2021 Jun 19. pii: 6306104. doi: 10.1093.
PMID: 34146100